13th C1-inhibitor deficiency and angioedema workshop

May 24, 2023|HAEi News|

Diagnostic and therapeutic applications of genetic research results The 13th C1-INH Deficiency and Angioedema Workshop took place in Budapest from 4-7 May. Nearly 400 participants arrived in the Hungarian capital this year from 42 [...]

KalVista delivers new data

May 8, 2023|HAEi News|

KalVista Pharmaceuticals, Inc. delivers two oral presentations and one poster presentation at the 13th C1-inhibitor Deficiency & Angioedema Workshop (C1 Workshop) in Budapest, Hungary. Rationale for the Short-term Prophylaxis Regimen with Sebetralstat in KONFIDENT-S: Michael [...]

New data from APeX-S clinical trial

April 27, 2023|HAEi News|

BioCryst Pharmaceuticals, Inc. announces new data from the APeX-S clinical trial, which evaluated oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of HAE, showing sustained reduction in disease burden for patients across multiple subgroups through [...]

Pharvaris reaches significant milestone

April 5, 2023|HAEi News|

At the presentation of the Pharvaris financial results for the fourth quarter and year ended 31 December 2022, CEO Berndt Modig says: “Our first in-patient data readout of deucrictibant in people living with HAE was [...]

Pharvaris presents positive study data

March 18, 2023|HAEi News|

At the 2023 HAEi Regional Conference APAC in Bangkok, Thailand, Pharvaris presents positive data from its Phase 2 RAPIDe-1 study of PHVS416 for the on-demand treatment of HAE attacks. Marc A. Riedl, M.D., M.S., Professor of [...]

KalVista makes significant advances

March 9, 2023|HAEi News|

At the operational update and release of the financial results for the third fiscal quarter ended 31 January 2023, the KalVista Pharmaceuticals, Inc. CEO Andrew Crockett says: “We have made significant advances at KalVista over this [...]

New data from ORLADEYO® clinical trials

February 24, 2023|HAEi News|

BioCryst Pharmaceuticals, Inc. announces new data from the APeX-S and APeX-2 clinical trials which evaluated oral, once-daily ORLADEYO® (berotralstat) for the prophylactic treatment of HAE demonstrating sustained reductions in attack rates and improvement in quality [...]

ORLADEYO build on strong initial launch

February 21, 2023|HAEi News|

BioCryst Pharmaceuticals, Inc. reports financial results for the fourth quarter and full year ended 31 December 2022, and provides a corporate update. “It has been exciting to build on our strong initial launch by doubling [...]

Astria Initiates Clinical Trial Of STAR-0215

February 13, 2023|HAEi News|

Astria Therapeutics, Inc. initiates the ALPHA-STAR Phase 1b/2 clinical trial of STAR-0215 in people living with HAE. Initial proof-of-concept results in HAE patients from single and multiple-dose cohorts are expected in mid-2024. “Our vision for [...]

The Lancet publishes Sebetralstat Phase 2 Data

February 10, 2023|HAEi News|

The Lancet, the international weekly medical journal, publishes results from the phase 2 trial evaluating the efficacy and safety of KalVista Pharmaceuticals, Inc.'s oral sebetralstat for the on-demand treatment of HAE. The phase 2 study was [...]

Stay Tuned

Be the first to know what’s going on in the world of HAE

Upcoming events

Jun 13, 2023
HAE Scandinavia's Spring Meeting in Odense

Jul 20, 2023 - Jul 23, 2023
2023 US HAEA National Summit

Sep 1, 2023 - Sep 3, 2023
2023 HAEi Regional Conference EMEA

Mar 15, 2024 - Mar 17, 2024
2024 HAEi Regional Conference Americas

>> View full event calendar

HAE related topics that might interest you

Global Perspectives

Magazine with timely information on the issues, activities, and events that are relevant to the global HAE community

HAEi Advocacy Academy

Courses, advocacy training, and tools to support people living with HAE and becoming an HAE advocate

HAEi Connect Member database

Free, secure online membership database and communications platform for HAEi’s member organizations

HAE Companion app

Access to HAEi’s emergency card in many languages and ACARE Centers, HAE knowledgeable hospitals and physicians

Stay tuned – sign up for our newsletter


Click here to sign up

HAEi hosted websites

Hosting of your national website or help for you to create a new website – naturally all in your native language

HAE TrackR app

Easy-to-use electronic diary of HAE treatments (preventative and on-demand), HAE attacks, and the impact HAE has on life